Hjem › Lungekreft › Ohio › Youngstown
Kliniske studier for Lungekreft i Youngstown, OH
4 studier for Lungekreft søker deltakere på steder i og rundt Youngstown (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- UPMC Cancer Center at UPMC Horizon, Farrell · 11 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Saint Elizabeth Youngstown Hospital, Youngstown
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- UPMC Cancer Center at UPMC Horizon, Farrell · 11 mi unna
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- UPMC Cancer Center at UPMC Horizon, Farrell · 11 mi unna
Lungekreft-studier i andre byer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Washington, DC41 studier
- Arlington, VA41 studier
- Chicago, IL41 studier
- Nashville, TN40 studier
- Baltimore, MD40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andre studier i Youngstown
- Ikke-småcellet lungekreft5 studier
- Plateepitelcancer i hode og hals5 studier
- Kolorektal kreft5 studier
- Munnhulekreft4 studier
- Brystkreft4 studier
- Prostatakreft4 studier
- Larynxcancer3 studier
- Melanom3 studier
- Nyrekreft (nyrecellekarcinom)3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.